Primary record
REBASTINIB
- CAS
- 1020172-07-9
- PubChem CID
- 25066467
- SMILES
- CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5
- Molecular Formula
- C30H28FN7O3
- Molecular Weight
- 553.598
- Exact Mass
- 553.2238
- InChI
- InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)
- InChIKey
- WVXNSAVVKYZVOE-UHFFFAOYSA-N
- LogP
- 6.048
- TPSA
- 123.06
Names and synonyms
- REBASTINIB
- DCC-2036
- 1020172-07-9
- DCC-2036 (Rebastinib)
- rebastinibum
- 3qri
- 3qrj
- Rebastinib [USAN]
- Rebastinib (USAN)
- DCC 2036
- Rebastinib [USAN:INN]
- REBASTINIB TOSYLATE
- Rebastinib/DCC-2036
- REBASTINIB [INN]
- DCC2036
- RefChem:930592
- DCC-2036 FREE BASE
- DCC-2036; Rebastinib
- MFCD19443646
- Rebastinib(DCC-2036)
- CHEBI:62166
- D0E0NM
- DP-1919
- REBASTINIB [WHO-DD]
- Rebastinib(DCC-2036 )
- C30H28FN7O3
- cc-606
- MLS006011270
- DCC-2036 (Rebastinib)?
- DTXSID40144533